Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04974606 · ClinicalTrials.gov registry record · NA
Effect of Coffeeberry on Mood, Motivation and Cognitive Performance
A NA study, sponsored by PepsiCo Global R&D.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04974606 is a NA study that has completed, run by PepsiCo Global R&D. The registered enrollment target is 30 participants.
The verdict
NCT04974606, a NA study, has completed, sponsored by PepsiCo Global R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The primary purpose is to test the short-term effects of the acute consumption of two novel beverages made from coffeeberries, the fruit of the coffee plant (Coffea arabica) benchmarked against caffeine on several aspects of cognitive performance. Preliminary studies suggest that flavanols and chlorogenic acids can enhance cognitive performance. It is unknown if drinks formulated with flavanols and chlorogenic acids (without high sugar or caffeine) improve cognition or mood to a similar extent as caffeine. Coffeeberry beverage comparisons will be made to a flavored positive control beverage containing caffeine and a flavored placebo beverage.
Interventions
- DIETARY_SUPPLEMENT Cherry-flavored still beverage
- OTHER Placebo cherry-flavored still beverage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-06-28 |
| Est. Completion | 2016-12-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04974606
The ClinicalTrials.gov registry entry for NCT04974606 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PepsiCo Global R&D, which has 47 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cherry-flavored still beverage is the first listed.
NCT04974606 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04974606 about?
NCT04974606 is a clinical study titled "Effect of Coffeeberry on Mood, Motivation and Cognitive Performance". The primary purpose is to test the short-term effects of the acute consumption of two novel beverages made from coffeeberries, the fruit of the coffee plant (Coffea arabica) benchmarked against caffeine on several aspects of cognitive performance. Preliminary studies suggest that flavanols and chlo...
What is the current status of trial NCT04974606?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-06-28. Estimated completion is 2016-12-16.
What interventions are being tested in trial NCT04974606?
The interventions under investigation include: Cherry-flavored still beverage (DIETARY_SUPPLEMENT), Placebo cherry-flavored still beverage (OTHER).
Who is sponsoring clinical trial NCT04974606?
This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.